Richard Eastell

1.1k total papers · 70.4k total citations
631 papers, 42.3k citations indexed

About

Richard Eastell is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, Richard Eastell has authored 631 papers receiving a total of 42.3k indexed citations (citations by other indexed papers that have themselves been cited), including 429 papers in Orthopedics and Sports Medicine, 282 papers in Oncology and 167 papers in Surgery. Recurrent topics in Richard Eastell's work include Bone health and osteoporosis research (408 papers), Bone health and treatments (279 papers) and Bone Metabolism and Diseases (120 papers). Richard Eastell is often cited by papers focused on Bone health and osteoporosis research (408 papers), Bone health and treatments (279 papers) and Bone Metabolism and Diseases (120 papers). Richard Eastell collaborates with scholars based in United Kingdom, United States and France. Richard Eastell's co-authors include R.A. Hannon, Nicola Peel, Steven R. Cummings, B. Lawrence Riggs, Aubrey Blumsohn, K.E. Naylor, Dennis M. Black, Angela J. Rogers, Jennifer Walsh and Ian R. Reid and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Richard Eastell

614 papers receiving 40.9k citations

Hit Papers

Denosumab for Prevention ... 2000 2026 2008 2017 2009 2000 2010 2014 2016 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
    2009 2.4k citations Steven R. Cummings, Javier San Martín et al. New England Journal of Medicine profile →
  2. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
    2000 1.2k citations Jean‐Yves Reginster, H. W. Minne et al. Osteoporosis International profile →
  3. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
    2010 857 citations Samuel D Vasikaran, Richard Eastell et al. Osteoporosis International profile →
  4. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    2014 794 citations John P. Bilezikian, Maria Luisa Brandi et al. The Journal of Clinical Endocrinology & Metabolism profile →
  5. Postmenopausal osteoporosis
    2016 587 citations Richard Eastell, Terence W O’Neill et al. Nature Reviews Disease Primers profile →
  6. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial
    2009 571 citations Douglas Wardlaw, Steven R. Cummings et al. The Lancet profile →
  7. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
    2000 549 citations B. Lawrence Riggs, Elizabeth J. Atkinson et al. Journal of Clinical Investigation profile →
  8. The Use of Biochemical Markers of Bone Turnover in Osteoporosis
    2000 548 citations Pierre D. Delmas, Richard Eastell et al. Osteoporosis International profile →
  9. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
    2019 490 citations Richard Eastell, Dennis M. Black et al. The Journal of Clinical Endocrinology & Metabolism profile →
  10. The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
    2011 473 citations Dennis M. Black, Ian R. Reid et al. Journal of Bone and Mineral Research profile →
  11. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
    2017 449 citations Steven R. Cummings, Serge Ferrari et al. Journal of Bone and Mineral Research profile →
  12. Use of bone turnover markers in postmenopausal osteoporosis
    2017 395 citations Richard Eastell, Paweł Szulc The Lancet Diabetes & Endocrinology profile →
  13. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
    2012 394 citations Nelson B. Watts, Robert A. Adler et al. The Journal of Clinical Endocrinology & Metabolism profile →
  14. Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
    2017 339 citations Elena Tsourdi, Bente Langdahl et al. Bone profile →
  15. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
    2020 250 citations Dolores Shoback, Dennis M. Black et al. The Journal of Clinical Endocrinology & Metabolism profile →
  16. Bone fragility in diabetes: novel concepts and clinical implications
    2022 237 citations Lorenz C. Hofbauer, Björn Busse et al. The Lancet Diabetes & Endocrinology profile →
  17. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
    2020 236 citations Dennis M. Black, Erik J. Geiger et al. New England Journal of Medicine profile →
  18. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
    2017 226 citations Paweł Szulc, K.E. Naylor et al. Osteoporosis International profile →
  19. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials
    2019 220 citations Mary Bouxsein, Richard Eastell et al. Journal of Bone and Mineral Research profile →
  20. Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS
    2020 216 citations Elena Tsourdi, M. Carola Zillikens et al. The Journal of Clinical Endocrinology & Metabolism profile →
  21. Bone Turnover Markers: Basic Biology to Clinical Applications
    2022 154 citations Marian Schini, Tatiane Vilaça et al. Endocrine Reviews profile →
  22. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024
    2024 29 citations Felicia Cosman, E. Michael Lewiecki et al. Journal of Bone and Mineral Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Richard Eastell 26.5k 17.5k 11.7k 9.8k 6.0k 631 42.3k
Pierre D. Delmas 28.0k 1.1× 16.7k 1.0× 12.5k 1.1× 8.1k 0.8× 6.5k 1.1× 403 45.0k
Robert R. Recker 21.9k 0.8× 12.9k 0.7× 14.5k 1.2× 4.8k 0.5× 5.7k 1.0× 464 39.4k
Dennis M. Black 29.9k 1.1× 15.3k 0.9× 9.7k 0.8× 12.6k 1.3× 5.7k 1.0× 325 43.5k
Claus Christiansen 20.3k 0.8× 12.8k 0.7× 11.3k 1.0× 6.4k 0.7× 5.5k 0.9× 681 45.6k
John А. Kanis 39.1k 1.5× 18.4k 1.1× 14.5k 1.2× 21.7k 2.2× 6.3k 1.1× 593 60.3k
Sundeep Khosla 21.5k 0.8× 14.9k 0.9× 21.2k 1.8× 7.7k 0.8× 4.8k 0.8× 508 51.5k
Ego Seeman 21.6k 0.8× 9.0k 0.5× 8.1k 0.7× 7.8k 0.8× 3.9k 0.7× 377 31.0k
Ian R. Reid 17.2k 0.6× 11.0k 0.6× 8.4k 0.7× 4.2k 0.4× 6.8k 1.1× 490 31.3k
B. Lawrence Riggs 29.3k 1.1× 15.1k 0.9× 18.7k 1.6× 9.9k 1.0× 8.6k 1.4× 390 55.4k
John P. Bilezikian 17.0k 0.6× 15.4k 0.9× 10.6k 0.9× 10.6k 1.1× 7.0k 1.2× 621 43.2k

Countries citing papers authored by Richard Eastell

Since Specialization
Citations

This map shows the geographic impact of Richard Eastell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Eastell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Eastell more than expected).

Fields of papers citing papers by Richard Eastell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Eastell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Eastell. The network helps show where Richard Eastell may publish in the future.

Co-authorship network of co-authors of Richard Eastell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Eastell. A scholar is included among the top collaborators of Richard Eastell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Eastell. Richard Eastell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by San Ping Jiang Breakdown of academic impact, for papers by John W. Daly Breakdown of academic impact, for papers by Daniela Rus Breakdown of academic impact, for papers by Richard J. Simpson Breakdown of academic impact, for papers by Yanlin Song Breakdown of academic impact, for papers by Paul W. Hodges Breakdown of academic impact, for papers by Steven Laureys Breakdown of academic impact, for papers by Peter A. McCullough
Rankless by CCL
2026